International Prospective Registry on Local Treatment Approaches in MLS
NCT04699292 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2022-08-30
Summary
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Conditions
- Myxoid Liposarcoma
Interventions
- PROCEDURE
-
Surgery
Surgery
- RADIATION
-
Preoperative RT 36Gy
Preoperative radiotherapy to 36Gy (equivalent)
- RADIATION
-
Preoperative RT 50Gy
Preoperative radiotherapy to 50Gy (equivalent)
- RADIATION
-
Postoperative RT 50-66Gy
Postoperative radiotherapy to 50-66Gy (equivalent)
- RADIATION
-
RT 36Gy
Definitive radiotherapy to 36Gy (equivalent)
Sponsors & Collaborators
-
Radboud University Medical Center
collaborator OTHER -
Maastro Clinic, The Netherlands
collaborator OTHER -
University Medical Center Groningen
collaborator OTHER -
Leiden University Medical Center
collaborator OTHER -
Vienna General Hospital
collaborator OTHER -
M.D. Anderson Cancer Center
collaborator OTHER -
University Hospital, Antwerp
collaborator OTHER -
Universitetssykehus
collaborator UNKNOWN -
Haukeland University Hospital
collaborator OTHER -
Universitäts-Frauenklinik Graz
collaborator OTHER -
University Hospital Heidelberg
collaborator OTHER - collaborator OTHER
-
Aarhus University Hospital
collaborator OTHER -
National Cancer Center, Japan
collaborator OTHER_GOV -
Princess Margaret Hospital, Canada
collaborator OTHER -
MOUNT SINAI HOSPITAL
collaborator OTHER -
University of Sydney
collaborator OTHER -
Institute for Cancer Research and treatment
collaborator UNKNOWN -
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
collaborator OTHER -
Institut Curie
collaborator OTHER -
ANZSA (Australia and New Zealand Sarcoma Association)
collaborator UNKNOWN -
The Netherlands Cancer Institute
lead OTHER
Principal Investigators
-
Rick Haas, MD/PhD · The Netherlands Cancer Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-18
- Primary Completion
- 2031-01-31
- Completion
- 2031-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
NCT06859801 ·Status: RECRUITING
-
Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma (SPARE-01)
NCT05167994 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiotherapy for Head and Neck Tumors
NCT01344356 ·Status: COMPLETED ·Phase: PHASE4
-
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
NCT00914355 ·Status: COMPLETED ·Phase: PHASE2
-
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
NCT00589121 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors
NCT04242342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Optimization of Radiotherapy in Treatment of Painful Bone Metastasis
NCT00610272 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal Metastases
NCT05060653 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
NCT03416803 ·Status: UNKNOWN ·Phase: NA
-
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
NCT07090122 ·Status: RECRUITING ·Phase: NA
-
Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma
NCT02805530 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
NCT00567970 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Y90 Therapy for Radiation Lobectomy
NCT04390724 ·Status: RECRUITING
-
Standardization of Multi-modal Tumor Ablation Therapy System
NCT03223142 ·Status: UNKNOWN ·Phase: NA
-
Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor
NCT02086721 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer
NCT03461822 ·Status: UNKNOWN
-
Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma
NCT01841047 ·Status: COMPLETED ·Phase: NA
-
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
NCT01169129 ·Status: WITHDRAWN ·Phase: PHASE3
-
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
NCT03721341 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
NCT02713269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
NCT04339218 ·Status: RECRUITING ·Phase: PHASE3
-
Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases
NCT04397978 ·Status: RECRUITING
-
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
NCT00922974 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases
NCT02933242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
NCT04122469 ·Status: RECRUITING ·Phase: NA